Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

Liu S, Wu LC, Pang J, Santhanam R, Schwind S, Wu YZ, Hickey CJ, Yu J, Becker H, Maharry K, Radmacher MD, Li C, Whitman SP, Mishra A, Stauffer N, Eiring AM, Briesewitz R, Baiocchi RA, Chan KK, Paschka P, Caligiuri MA, Byrd JC, Croce CM, Bloomfield CD, Perrotti D, Garzon R, Marcucci G.

Cancer Cell. 2010 Apr 13;17(4):333-47. doi: 10.1016/j.ccr.2010.03.008.

2.

Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits.

Brioschi M, Fischer J, Cairoli R, Rossetti S, Pezzetti L, Nichelatti M, Turrini M, Corlazzoli F, Scarpati B, Morra E, Sacchi N, Beghini A.

Neoplasia. 2010 Nov;12(11):866-76.

3.

Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia.

Mims A, Walker AR, Huang X, Sun J, Wang H, Santhanam R, Dorrance AM, Walker C, Hoellerbauer P, Tarighat SS, Chan KK, Klisovic RB, Perrotti D, Caligiuri MA, Byrd JC, Chen CS, James Lee L, Jacob S, Mrózek K, Bloomfield CD, Blum W, Garzon R, Schwind S, Marcucci G.

Leukemia. 2013 Apr;27(4):871-8. doi: 10.1038/leu.2012.342. Epub 2012 Nov 26.

4.

Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia.

Huang X, Schwind S, Yu B, Santhanam R, Wang H, Hoellerbauer P, Mims A, Klisovic R, Walker AR, Chan KK, Blum W, Perrotti D, Byrd JC, Bloomfield CD, Caligiuri MA, Lee RJ, Garzon R, Muthusamy N, Lee LJ, Marcucci G.

Clin Cancer Res. 2013 May 1;19(9):2355-67. doi: 10.1158/1078-0432.CCR-12-3191. Epub 2013 Mar 14.

5.

MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia.

Gao XN, Lin J, Gao L, Li YH, Wang LL, Yu L.

Leuk Res. 2011 Sep;35(9):1226-32. doi: 10.1016/j.leukres.2011.06.010. Epub 2011 Jul 2.

PMID:
21724256
6.

The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma.

Yuan JH, Yang F, Chen BF, Lu Z, Huo XS, Zhou WP, Wang F, Sun SH.

Hepatology. 2011 Dec;54(6):2025-35. doi: 10.1002/hep.24606.

PMID:
21837748
7.

MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.

Gao XN, Lin J, Li YH, Gao L, Wang XR, Wang W, Kang HY, Yan GT, Wang LL, Yu L.

Oncogene. 2011 Aug 4;30(31):3416-28. doi: 10.1038/onc.2011.62. Epub 2011 Mar 14.

PMID:
21399664
8.

Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia.

Sampath D, Liu C, Vasan K, Sulda M, Puduvalli VK, Wierda WG, Keating MJ.

Blood. 2012 Feb 2;119(5):1162-72. doi: 10.1182/blood-2011-05-351510. Epub 2011 Nov 16.

9.

The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia.

Larizza L, Magnani I, Beghini A.

Leuk Lymphoma. 2005 Feb;46(2):247-55. Review.

PMID:
15621809
10.

KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor.

Kohl TM, Schnittger S, Ellwart JW, Hiddemann W, Spiekermann K.

Blood. 2005 Apr 15;105(8):3319-21. Epub 2004 Dec 23.

11.

Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia.

Xing CY, Hu XQ, Xie FY, Yu ZJ, Li HY, Bin-Zhou, Wu JB, Tang LY, Gao SM.

FEBS Lett. 2015 Jul 8;589(15):1981-7. doi: 10.1016/j.febslet.2015.04.061. Epub 2015 May 12.

12.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
13.

MicroRNA 29b functions in acute myeloid leukemia.

Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA, Andreeff M, Croce CM.

Blood. 2009 Dec 17;114(26):5331-41. doi: 10.1182/blood-2009-03-211938. Epub 2009 Oct 22.

14.

High expression of c-kit mRNA predicts unfavorable outcome in adult patients with t(8;21) acute myeloid leukemia.

Gao X, Lin J, Gao L, Deng A, Lu X, Li Y, Wang L, Yu L.

PLoS One. 2015 Apr 10;10(4):e0124241. doi: 10.1371/journal.pone.0124241. eCollection 2015.

15.

miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.

Ovcharenko D, Stölzel F, Poitz D, Fierro F, Schaich M, Neubauer A, Kelnar K, Davison T, Müller-Tidow C, Thiede C, Bornhäuser M, Ehninger G, Brown D, Illmer T.

Exp Hematol. 2011 Oct;39(10):1030-1042.e7. doi: 10.1016/j.exphem.2011.07.008. Epub 2011 Jul 22.

PMID:
21784052
16.

A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.

Kong LM, Liao CG, Zhang Y, Xu J, Li Y, Huang W, Zhang Y, Bian H, Chen ZN.

Cancer Res. 2014 Jul 15;74(14):3764-78. doi: 10.1158/0008-5472.CAN-13-3555. Epub 2014 Jun 6.

17.

Lack of KIT or FMS internal tandem duplications but co-expression with ligands in AML.

Zheng R, Klang K, Gorin NC, Small D.

Leuk Res. 2004 Feb;28(2):121-6. Erratum in: Leuk Res. 2004 Nov;28(14):1241.

PMID:
14654075
18.

Suppression of type I collagen expression by miR-29b via PI3K, Akt, and Sp1 pathway in human Tenon's fibroblasts.

Li N, Cui J, Duan X, Chen H, Fan F.

Invest Ophthalmol Vis Sci. 2012 Mar 26;53(3):1670-8. doi: 10.1167/iovs.11-8670.

PMID:
22297492
19.

MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.

Kim WK, Park M, Kim YK, Tae YK, Yang HK, Lee JM, Kim H.

Clin Cancer Res. 2011 Dec 15;17(24):7584-94. doi: 10.1158/1078-0432.CCR-11-0166. Epub 2011 Oct 31.

20.

MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1.

Qin H, Zhu X, Liang J, Wu J, Yang Y, Wang S, Shi W, Xu J.

J Dermatol Sci. 2013 Jan;69(1):61-7. doi: 10.1016/j.jdermsci.2012.10.011. Epub 2012 Oct 24.

PMID:
23142053

Supplemental Content

Support Center